These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 36814229
21. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients. Marie JP, Marjanovic Z, Vekhoff A, Bouvet A, Chast F, Levy V, Baudard M, Legrand O, Rio B, Delmer A, Zittoun R. Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089 [Abstract] [Full Text] [Related]
22. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy. Fanci R, Paci C, Martinez RL, Fabbri A, Pecile P, Leoni F, Longo G. J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519 [Abstract] [Full Text] [Related]
23. Pediatric fever in neutropenia with bacteremia-Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study. Stergiotis M, Ammann RA, Droz S, Koenig C, Agyeman PKA. PLoS One; 2021 Jun; 16(2):e0246654. PubMed ID: 33577566 [Abstract] [Full Text] [Related]
28. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Yildirim I, Aytac S, Ceyhan M, Cetin M, Tuncer M, Cengiz AB, Secmeer G, Yetgin S. Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473 [Abstract] [Full Text] [Related]
29. An Emergent Change in Epidemiologic and Microbiological Characteristics of Bloodstream Infections in Adults With Febrile Neutropenia Resulting From Chemotherapy for Acute Leukemia and Lymphoma at Reference Centers in Chile, Ecuador, and Peru. Rabagliati R, Salazar G, Pérez-Lazo G, Iturrieta MP, Portillo D, Soria-Segarra C, Ojeda MJ, Flores J, Galarza M, Sandoval-Ahumada R, Cartes Aguilera P, Dimitrakis L, Avelga Reinoso F, Garcia P. Open Forum Infect Dis; 2024 Mar; 11(3):ofae052. PubMed ID: 38444817 [Abstract] [Full Text] [Related]
30. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India. Rajendranath R, Balasubramaniyum VK, Vijayakumar V, Ganesan P, Tenali GS. Indian J Cancer; 2014 Mar; 51(4):481-6. PubMed ID: 26842171 [Abstract] [Full Text] [Related]
34. [Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tobón Uribe, Colombia]. Madrid C, Díaz L, Combariza J, Gálvez K, Olaya V, Ramírez I, Donado J. Rev Chilena Infectol; 2013 Apr; 30(2):195-201. PubMed ID: 23677158 [Abstract] [Full Text] [Related]
36. [Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles]. Marie JP, Vekhoff A, Cony-Makhoul P, Fière D, Guy H, Herbrecht R, Milpied N, Pico JL, Plantier I. Presse Med; 1995 Feb 25; 24(8):397-401. PubMed ID: 7899419 [Abstract] [Full Text] [Related]
37. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients. Sezgin G, Acipayam C, Ozkan A, Bayram I, Tanyeli A. Asian Pac J Cancer Prev; 2014 Feb 25; 15(11):4549-53. PubMed ID: 24969883 [Abstract] [Full Text] [Related]